Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Health Care Poor Underserved. 2021;32(3):1619–1634. doi: 10.1353/hpu.2021.0153

Table 3.

Prevalence of conditions of interest, with 95% confidence intervals, based on the Elixhauser Comorbidities, of the homeless, non-homeless with high area deprivation, and non-homeless with non-high area deprivation. High area deprivation is defined as the top quintile of the Area Deprivation Index (ADI). Comorbidities are listed in order of prevalence in people experiencing homelessness.

Condition
% (95% CI)
Homeless
n = 15,920
High Area Deprivation
n = 351,279
Non-Homeless + Non-High Area Deprivation
n = 1,607,567
Depression (including MDD)* 48.1 (47.3, 48.9) 24.9 (24.7, 25.0) 20.1 (20.1, 20.2)
Anxiety, dissociative and somatoform disorders* 45.8 (45.0, 46.5) 25.1 (25.0, 25.2) 24.1 (24.0, 24.1)
Hypertension 44.2 (43.4, 44.9) 44.4 (44.2, 44.5) 37.7 (37.7, 37.8)
Drug abuse 41.1 (40.4, 41.9) 8.7 (8.6, 8.8) 3.2 (3.2, 3.2)
Pulmonary disease (chronic) 36.8 (36.1, 37.6) 27.5 (27.4, 27.7) 20.3 (20.2, 20.3)
Alcohol abuse 30.6 (29.9, 31.3) 7.3 (7.3, 7.4) 3.0 (3.0, 3.1)
Other neurological disorders 26.1 (25.4, 26.8) 14.1 (13.9, 14.2) 10.9 (10.8, 10.9)
Fluid and electrolyte disorders 25.9 (25.2, 26.6) 18.0 (17.9, 18.2) 12.7 (12.6, 12.7)
Other psychoses* 25.5 (24.8, 26.2) 6.4 (6.4, 6.5) 3.9 (3.9, 3.9)
Deficiency anemias 24.2 (23.5, 24.9) 22.8 (22.7, 23.0) 15.2 (15.1, 15.2)
Obesity 24.0 (23.3, 24.7) 26.8 (26.6, 26.9) 16.3 (16.2, 16.3)
Other neoplasms* 22.1 (21.5, 22.8) 25.2 (25.0, 25.3) 28.3 (28.2, 28.4)
Bipolar disorders* 21.9 (21.3, 22.5) 4.1 (4.1, 4.2) 2.2 (2.2, 2.3)
Liver disease 21.1 (20.4, 21.7) 9.1 (9.0, 9.2) 5.8 (5.8, 5.8)
Diabetes 19.2 (18.6, 19.8) 20.5 (20.4, 20.7) 13.9 (13.8, 13.9)
CVD* 18.4 (17.8, 19.0) 16.0 (15.9, 16.2) 14.3 (14.2, 14.3)
Schizophrenic disorders* 18.3 (17.7, 18.9) 2.7 (2.7, 2.8) 0.6 (0.6, 0.7)
Hepatitis* 18.1 (17.5, 18.7) 4.8 (4.7, 4.8) 2.1 (2.1, 2.1)
Weight loss 14.8 (14.3, 15.4) 10.9 (10.8, 11.0) 7.0 (7.0, 7.0)
Peripheral vascular disorders 9.9 (9.4, 10.4) 9.1 (9.0, 9.2) 7.2 (7.2, 7.3)
Hypotension* 8.5 (8.1, 9.0) 5.8 (5.7, 5.9) 4.5 (4.4, 4.5)
Congestive heart failure 8.4 (7.9, 8.8) 8.4 (8.3, 8.5) 5.8 (5.7, 5.8)
Rheumatoid arthritis/collagen vascular diseases 8.0 (7.6, 8.4) 7.9 (7.9, 8.0) 8.2 (8.2, 8.3)
Coagulopathy 6.7 (6.3, 7.1) 4.8 (4.8, 4.9) 4.6 (4.6, 4.6)
Renal failure 6.6 (6.3, 7.0) 7.8 (7.7, 7.9) 5.4 (5.4, 5.5)
Kidney disease* 6.4 (6.1, 6.8) 7.7 (7.6, 7.8) 5.3 (5.3, 5.3)
Hypothyroidism 5.5 (5.2, 5.9) 7.9 (7.9, 8.0) 11.8 (11.7, 11.8)
Valvular disease 4.6 (4.3, 5.0) 4.7 (4.6, 4.8) 5.8 (5.8, 5.9)
Peptic ulcer disease excluding bleeding 4.6 (4.3, 4.9) 3.2 (3.2, 3.3) 2.3 (2.2, 2.3)
Pulmonary circulation disorders 4.4 (4.1, 4.8) 4.1 (4.0, 4.2) 3.0 (3.0, 3.1)
Blood loss anemia 4.2 (3.9, 4.6) 4.1 (4.1, 4.2) 1.8 (1.8, 1.9)
Solid tumor without metastasis 4.2 (3.9, 4.5) 6.4 (6.3, 6.5) 8.5 (8.5, 8.6)
Paralysis 4.1 (3.8, 4.4) 2.8 (2.8, 2.9) 1.5 (1.5, 1.6)
HIV/AIDS 2.8 (2.6, 3.1) 0.8 (0.8, 0.8) 0.2 (0.2, 0.2)
Metastatic cancer 2.5 (2.3, 2.8) 3.0 (3.0, 3.1) 3.3 (3.3, 3.3)
Tuberculosis* 1.9 (1.7, 2.1) 0.7 (0.7, 0.7) 0.3 (0.3, 0.3)
Lymphoma 0.5 (0.4, 0.7) 0.8 (0.8, 0.9) 1.1 (1.1, 1.1)

CVD = Cardiovascular disease; HIV/AIDS = Human immunodeficiency virus/Acquired immunodeficiency syndrome

*

Not an Elixhauser comorbidity and thus individuals may be counted in multiple comorbidity categories.